“ME-TOO” DRUG REVOLUTION: A PRODUCT OF REGULATORY IMPROPRIETY
Journal Title: International Journal of Drug Regulatory Affairs - Year 2016, Vol 4, Issue 3
Abstract
Amidst all the brouhaha, often the regulatory agencies, for instance the United States Food and Drug Administration’s (US-FDA) role in bringing about what is being so cleverly termed as the ‘me-too drug revolution’, has escaped scrutiny. Bearing in mind the pre-eminent status of USFDA in regulatory world, it would be useful to examine some of their strategies that have helped facilitate this revolution. The surge seen in the approval of me-too drugs can be attributed to a regressive policy of evaluating a new drug against a placebo or using non-inferiority trials, which in turn has often allowed an easy rite of passage for the me-too drugs. So has the Prescription Drug User Fees Act (PDUFA) by allowing rapid approval of drugs. However, this has not necessarily translated into safer drugs! Further, advisory committees that are rife with conflicts of interest, a legally weakened status bestowed upon the USFDA and a no-holds barred approach adopted by the industry towards direct to consumer advertisements (DTCA), has allowed me-too drugs with dubious safety profiles to flourish in the markets. It has been suggested on many fronts that by undertaking measures, for instance an increment in the US congress appropriations to the US-FDA, vesting punitive powers in the agency to rein in the errant pharmaceutical companies as well as dealing with the conflicts of interest within the advisory committees could go a long way in preventing the undue and potentially dangerous proliferation of me-too drugs.
Authors and Affiliations
Bhattacharjee Dipanjan, Agarwal Saurabh
Keywords
Related Articles
- EP ID EP337004
- DOI 10.22270/ijdra.v4i3.185
- Views 106
- Downloads 0
SIMULTANEOUS UV SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF CEFADROXIL AND PROBENECID IN TABLET DOSAGE FORM
Two methods for simultaneous estimation of Cefadroxil and Probenecid in combined tablet dosage form have been developed. The first UV spectrophotometric method was a determination using the simultaneous equation method a...
REVIEW ON SPONSOR / APPLICANT MEETINGS WITH FDA: HIGHLIGHTS OF NEW GUIDANCE OVER EXISTING
The United States Department of Health and Human Services has a federal agency called the Food and Drug Administration (FDA or USFDA). A pre-planned assembling of two or more people who have been together for the purpose...
Comparative Study of Triglyceride Level in Ischemic Heart Disease Patients in different age groups of Patients in south east Rajasthan
Backgrounds: Elevated body triglycerides have been implicated as a risk factor of ischemic heart disease (IHD). Objectives: To study the association of serum triglyceride with ischemic heart disease and to assess the rel...
MARKETING AUTHORIZATION APPLICATION (MAA) FOR EUROPE MARKET
This article states requirement of Marketing Authorization Application to get registration of Drug Product to EEA. The procedures for application of marketing authorization are: Centralised procedure, National procedure,...
FEEBLE REGULATORY AFFAIRS WEAKEN THE BACKBONE OF INDIAN DRUG INDUSTRIES
India is emerging as a global outsourcing power house in almost all fields including Drugs and Pharmaceutical sector. Now it becomes a hub to conduct clinical trials and contract researches. Pharmaceutical industry curre...